StephenJShidelerMD

Dermatology • Carmel, IN

Physician

Join to view full profile

Dr. Shideler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shideler's full profile

Already have an account?

Office
755 W Carmel Dr
Suite101
Carmel, IN 46032
Phone+1 317-846-2396

Fax+1 317-846-1699
Is this information wrong?

Education & Training

Indiana University School of MedicineResidency, Dermatology, 1976 - 1979
Indiana University School of MedicineInternship, Internal Medicine, 1974 - 1975
Indiana University School of MedicineClass of 1974

Certifications & Licensure

FL State Medical License 2019 - 2025
IN State Medical License 1974 - 2019
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis Start of enrollment: 2014 May 01
Completed
Phase 4
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2014 Apr 01
Completed
Phase 2
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities Start of enrollment: 2014 May 01
Completed
Phase 3
Twelve Month Follow-Up of CP0108 Start of enrollment: 2014 Aug 01
Completed
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Start of enrollment: 2014 Sep 01
Completed
Phase 2
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face Start of enrollment: 2016 Mar 01
Completed
Phase 2
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp Start of enrollment: 2017 Mar 01
Withdrawn
Phase 3
Join now to see all

Press Mentions

Topical Glycopyrronium Tosylate (DRM04) for the Treatment of Primary Axillary Hyperhidrosis: Pooled Results from the ATMOS-1 and ATMOS-2 Phase 3 Randomized Controlled TrialsAugust 2nd, 2018
Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisAugust 2nd, 2018

Professional Memberships

American Academy of Dermatology - AAD
Fellow